Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023283 · ClinicalTrials.gov registry record · Phase 2
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00023283 is a Phase 2 study that has completed, run by Yale University.
The verdict
NCT00023283, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to compare the Standard Medical Management (SMM) vs. SMM enhanced with additional education about addiction and recovery (Enhanced Medical Management, EMM)
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-08 |
| Est. Completion | 2004-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023283
The ClinicalTrials.gov registry entry for NCT00023283 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00023283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00023283 about?
NCT00023283 is a clinical study titled "Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1". The purpose of this study is to compare the Standard Medical Management (SMM) vs. SMM enhanced with additional education about addiction and recovery (Enhanced Medical Management, EMM)
What is the current status of trial NCT00023283?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-08. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00023283?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00023283?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.